Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter July 2014

Gene Therapy Net Banner
News: Renewed hope for gene therapy in rare disease
New virus serotypes are safely used as ‘DNA transporters’ to successfully deliver genes to deficient cells. Between 30 and 40 million people in Europe suffer from rare diseases—many of them children. As most of these diseases have genetic origins, gene therapy is a major hope for their future cure. Until now, however, there have been very few successful trials. Now, the EU-funded project AIPGENE, due to be completed in 2014, may have made significant progress in a gene therapy approach.
The project focussed on the genetic liver disorder, Acute Intermittent Porphyria (AIP). Through an early stage clinical trial, in phase I, it demonstrated the viability of a new approach, based on a so-called, adeno-associated vector (AAV). This is a ‘DNA transporter’ derived from a type of virus and carries the therapeutic gene to liver cells, known as hepatocytes.


Summer School: Power of Viral Vectors in Gene Therapy
The preliminary programme of Power of Viral Vectors in Gene Therapy and Basic Science Summer School consists of invited speakers talks, oral presentations, poster sessions, and an excursion. The Summer School will cover the different aspects of viral vectors use, ranging from the gene therapy to the basic science. The target audience of this meeting consists of virologists, microbiologists, oncologists, infectious disease doctors and other healthcare professionals involved in the treatment of monogenic diseases and cancer. A few invited speakers from the gene therapy biotech companies will join us as well. We encourage the scientists, people from the industry, the postdocs and the PhD students to attend this meeting. We also encourage the people from all over the Europe to join us. The Organizing Committee has secured a limited number of FEMS meeting attendance grants for the young scientists, which will be used to support the attendance of young microbiologists from all over the Europe. Approximatelly 70 paticipants are expected at the School.

Date: 17 - 20 September 2014
Location: Primošten, Croatia


Conference: XXII Congress of the European Society of Gene and Cell Therapy (ESGCT)
Registrations now open, register before July 31 for early bird rates. The main congress will take place from October 23rd to 26th. The ESGCT Clinical Trials Workshop, the Education Day and the Public Day are taking place on October 23rd, please check back regularly for updates to the programme.

Abstract submission deadline is 31st July 2014. IMPORTANT: please read the abstract guidelines carefully.

Date: 23 – 26 October 2014
Location: The Hague, The Netherlands


Company: Oxford Genetics Ltd
Oxford Genetics provides a wide range of genetic materials for the creation of plasmid and virus based gene expression systems. Using a modular DNA assembly system, creating complex genetic systems is made significantly more efficient.


- 21 – 23 July 2014, DNA Vaccines 2014, San Diego, CA
- 6 – 8 August 2014, The 20th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Tokio, Japan
- 17 – 20 September 2014, Summer school: Power of Viral Vectors in Gene Therapy, Primošten, Croatia
- 25 – 27 September 2014, 14th Annual Meeting of the International Society for Cell & Gene Therapy of Cancer, Amsterdam, The Netherlands
- 23 – 26 October 2014, XXII Congress of the European Society of Gene and Cell Therapy (ESGCT), The Hague, The Netherlands
- 27 – 29 October 2014, 3rd International Conference and Exhibition on Cell & Gene Therapy, Las Vegas, NV
- 17 – 20 September 2014, Summer school: Power of Viral Vectors in Gene Therapy, Primošten, Croatia
- 29 April – 1 May 2015, 9th Australasian Gene Therapy Society Meeting (AGTS), Melbourne, Australia
- 13 - 16 May 2015, American Society of Gene and Cell Therapy (ASGCT) 18th Annual Meeting, New Orleans, Louisiana
- 9 - 11 June 2015, Annual conference of the British Society for Gene Therapy (BSGT), Glasgow, UK


Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net and Chikungunya Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?